Triglyceride-rich lipoprotein interactions with Lp(a)

Area of Science:

• Cardiovascular Science
• Lipid Metabolism Research

Background:

• Elevated lipoprotein(a) (Lp(a)) is a risk factor for cardiovascular disease (CVD).
• An inverse relationship exists between plasma triglyceride (TG) levels and Lp(a) levels, but the underlying mechanism is unclear.

Purpose of the Study:

• To investigate the potential role of lipoprotein lipase (LPL) in mediating the inverse relationship between TG and Lp(a).
• To explore the interaction between Lp(a), VLDL-TG, and LPL activity.

Main Methods:

• Assessed Lp(a) and TG levels in subjects with and without coronary artery disease (CAD).
• Evaluated the effect of Lp(a) and LDL2 on VLDL-TG degradation by LPL.
• Performed binding analyses to determine Lp(a) interaction with VLDL and its lipolytic remnants.

Main Results:

• A significantly reduced incidence of increased Lp(a) levels was observed in subjects with TG > 150 mg/dl compared to those with TG < 150 mg/dl, irrespective of CAD status.
• Lp(a) and LDL2 showed minimal inhibition (13%) on VLDL-TG degradation by LPL.
• Binding analyses revealed no significant differences in Lp(a) binding to VLDL and LDL, with lipolysis reducing binding by only 30% at 75% VLDL-TG degradation.

Conclusions:

• The inverse relationship between elevated plasma TG and Lp(a) is not mediated by LPL activation.
• Lp(a) does not appear to bind effectively to VLDL or its lipolytic remnants to influence LPL activity.
• The study hypothesizes that enhanced clearance of TG-rich lipoproteins via receptor-mediated events in individuals with higher Lp(a) may explain the observed inverse relationship.